As of 2024-12-13, the EV/EBITDA ratio of AstraZeneca PLC (AZN.L) is 11.92. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AZN.L's latest enterprise value is 184,170.97 mil GBP. AZN.L's TTM EBITDA according to its financial statements is 15,455.00 mil GBP. Dividing these 2 quantities gives us the above AZN.L EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 10.1x - 13.2x | 12.8x |
| Forward P/E multiples | 12.2x - 13.8x | 13.1x |
| Fair Price | 6,149.54 - 8,978.92 | 7,673.40 |
| Upside | -41.8% - -15.0% | -27.4% |
| Date | EV/EBITDA |
| 2024-12-12 | 15.18 |
| 2024-12-11 | 15.15 |
| 2024-12-10 | 15.11 |
| 2024-12-09 | 15.35 |
| 2024-12-06 | 15.29 |
| 2024-12-05 | 15.25 |
| 2024-12-04 | 15.07 |
| 2024-12-03 | 15.47 |
| 2024-12-02 | 15.17 |
| 2024-11-29 | 15.24 |
| 2024-11-28 | 15.22 |
| 2024-11-27 | 15.14 |
| 2024-11-26 | 15.09 |
| 2024-11-25 | 15.06 |
| 2024-11-22 | 15.06 |
| 2024-11-21 | 14.54 |
| 2024-11-20 | 14.42 |
| 2024-11-19 | 14.49 |
| 2024-11-18 | 14.35 |
| 2024-11-15 | 14.43 |
| 2024-11-14 | 14.83 |
| 2024-11-13 | 14.64 |
| 2024-11-12 | 14.45 |
| 2024-11-11 | 14.44 |
| 2024-11-08 | 14.34 |
| 2024-11-07 | 14.11 |
| 2024-11-06 | 14.36 |
| 2024-11-05 | 14.61 |
| 2024-11-04 | 15.79 |
| 2024-11-01 | 15.76 |
| 2024-10-31 | 15.79 |
| 2024-10-30 | 16.00 |
| 2024-10-29 | 16.41 |
| 2024-10-28 | 16.53 |
| 2024-10-25 | 16.51 |
| 2024-10-24 | 16.62 |
| 2024-10-23 | 16.79 |
| 2024-10-22 | 16.84 |
| 2024-10-21 | 16.92 |
| 2024-10-18 | 16.94 |
| 2024-10-17 | 17.04 |
| 2024-10-16 | 17.04 |
| 2024-10-15 | 16.82 |
| 2024-10-14 | 16.93 |
| 2024-10-11 | 16.71 |
| 2024-10-10 | 16.72 |
| 2024-10-09 | 16.70 |
| 2024-10-08 | 16.60 |
| 2024-10-07 | 16.77 |
| 2024-10-04 | 16.67 |